Atlas FDA

VENTANA PD-L1(SP142) Assay

FDA premarket approval P160002/S007 · decided 2018-09-13

Approval details

PMA number
P160002
Supplement
S007
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VENTANA PD-L1(SP142) Assay
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Applicant
Ventana Medical Systems, Inc.
Date received
2018-06-18
Decision date
2018-09-13
Days to decision
87 days
Decision code
APPR
Product code
PLS
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
Approval for implementing a BenchMark Scanners software supplement for Ventana Systems Software (VSS) 12.3 on the BenchMark ULTRA Instrument.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20